Patent · US Active

Antibodies that specifically bind PD-1 and methods of use

US11746161B2 · kind B2 · utility

2Cited by
10References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2020
Grant dateSep 5, 2023
Priority date
Expiry dateAug 12, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Antibodies that specifically bind PD-1 or antigen binding fragments thereof, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are useful in the treatment of an inflammatory or immune disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.